Medical Training AIAI in Drug Discovery
You'll be able to explain how AI tools are used across the drug development pipeline and discuss their clinical and regulatory implications with colleagues and patients.
What this track covers
This track covers how machine learning is applied to pharmaceutical research, from target identification and protein structure prediction to virtual screening and clinical trial design. It also addresses AI-driven drug repurposing and the current regulatory landscape for AI/ML tools in drug development.
What you will practice
- Explain how AI-based target identification narrows candidate compounds
- Describe how protein structure prediction tools inform molecular design
- Discuss how AI is used in clinical trial patient selection and site selection
- Recognize examples of AI-driven drug repurposing for existing compounds
- Summarize current regulatory considerations for AI/ML use in drug development
Simulator scenario
A virtual scenario where the clinician reviews an AI-assisted trial design proposal and identifies questions to raise about patient selection criteria and endpoint choices.
Board question topics
- AI methods in target identification
- Protein structure prediction basics
- AI applications in clinical trial design
- Regulatory considerations for AI/ML in drug development
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free